UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000011592
Receipt No. R000013553
Official scientific title of the study The impact of continuous positive airway pressure (CPAP) on aortic aneurysms in patients with obstructive sleep apnea
Date of disclosure of the study information 2014/01/01
Last modified on 2016/08/29 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The impact of continuous positive airway pressure (CPAP) on aortic aneurysms in patients with obstructive sleep apnea
Title of the study (Brief title) The impact of CPAP on aortic aneurysms in patients with OSA
Region
Japan

Condition
Condition obstructive sleep apnea
aortic aneurysm
Classification by specialty
Cardiology Pneumology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study is aimed at investigating whether CPAP therapy can attenuate aortic aneurysm expansion in patients with obstructive sleep apnea, in order to explore the causal relationship between aortic aneurysm expansion and obstructive sleep apnea.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes The changes in the expansion rate of aortic aneurysms (mm/year) before and after the CPAP treatment
Key secondary outcomes 1. Expansion rate (mm/year) of aortic aneurysms in patients without CPAP treatment
2. Prevalence of OSA in patients with aortic aneurysm
3. Events associated with aortic aneurysm
4. Cardiovascular events
5. Changes in biomarkers of aortic aneurysm
6. Changes in blood pressure and endothelial function
7. Changes in epicardial fat and visceral fat volume
8. Changes in sleep duration

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -but assessor(s) are blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Patients with apnea-hypopnea index (AHI)>20
CPAP treatment (during sleep, everyday)
Interventions/Control_2 Patients with apnea-hypopnea index (AHI)<20
No treatment
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. Patients with thoracic aortic aneurysm (TAA) or abdominal aortic aneurysm (AAA)
2. Diameter of aortic aneurysm has been measured by CT for at least one year
3. Receiving appropriate treatments for hypertension, dyslipidemia, and/or diabetes
Key exclusion criteria 1. Previous or current treatments for sleep apnea.
2. Previous treatment for aortic aneurysm
3. Planned intervention for aortic aneurysm
4. Central sleep apnea syndrome
5. Long-term oxygen therapy
6. Aortic aneurysm associated with hereditary diseases (e.g. Marfan syndrome)
7. Unable to use CPAP
8. Hope for treatments other than CPAP for OSA
9. Surgery of upper airway within 90 days


Target sample size 70

Research contact person
Name of lead principal investigator Kazuo Chin
Organization Graduate School of Medicine, Kyoto University
Division name Respiratory Care and Sleep Control Medicine
Address Shogoin 54, Kawahara-cho, Sakyo-Ku, Kyoto, Japan
TEL 81-(0)75-751-3852
Email chink@kuhp.kyoto-u.ac.jp

Public contact
Name of contact person Kazuo Chin
Organization Graduate School of Medicine, Kyoto University
Division name Respiratory Care and Sleep Control Medicine
Address Shogoin 54, Kawahara-cho, Sakyo-Ku, Kyoto, Japan
TEL 81-(0)75-751-3852
Homepage URL http://kukonai.com/office/class/
Email ryotkw@gmail.com

Sponsor
Institute Graduate School of Medicine, Kyoto University
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 01 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2013 Year 08 Month 06 Day
Anticipated trial start date
2014 Year 01 Month 01 Day
Last follow-up date
2016 Year 12 Month 31 Day
Date of closure to data entry
2016 Year 12 Month 31 Day
Date trial data considered complete
2016 Year 12 Month 31 Day
Date analysis concluded
2017 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 08 Month 27 Day
Last modified on
2016 Year 08 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013553